Tempus receives FDA approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval (PMA) application for its…